Clinical Trial Results:
A 52-week open label extension study to evaluate the safety and tolerability of AIN457 (anti IL-17 monoclonal antibody) in patients with moderate to severe Crohn’s
disease
Summary
|
|
EudraCT number |
2009-011621-14 |
Trial protocol |
AT DE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
21 Oct 2021
|
First version publication date |
16 Sep 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
CAIN457A2202E1.CTR.18Aug2016 Full results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.